Search Results

Asa is interviewed by a well-known influencer on the topic. This is applicable to the dietary supplement industry as well. Read here: https://www.letstalkhemp.com/hemp-influencers/ < Back Influencers and CBD: Be Careful What You Say Cait Curley and Asa Waldstein Interview Asa is interviewed by a well-known influencer on the topic. This is applicable to the dietary supplement industry as well. Read here: https://www.letstalkhemp.com/hemp-influencers/ Read More Previous Next

Asa and other industry leaders weigh in < Back 2025 State of the Industry Sean Moloughney Interview Asa and other industry leaders weigh in Asa Waldstein, Principal, Supplement Advisory Group : "Looking at the past can help predict future regulatory enforcement. There has been no FDA enforcement of claims made on TikTok, and FTC’s enforcement has been limited to a few cases in which notable influencers did not disclose material connections. I expect this minimal enforcement to ramp up over the next year. Also, I predict more FDA biomarker enforcement, which up until this point has only involved heart disease-related statements like “reduces LDL.” This big question is “Will FDA also target GLP-1 statements?” I suspect we will see this appear in some supplement warning letters, but only when higher-risk statements like “prevents obesity” and cringeworthy “nature’s Ozempic” phrases are present." Read the full article here . Read More Previous Next

Former FDA officials and lawyers who advise clients on FDA regulations weigh in on a recent batch of warning letters targeting new dietary ingredients marketed in supplements. < Back NDI warning letters fuel criticism of FDA enforcement approach—again Josh Long Press Mention Former FDA officials and lawyers who advise clients on FDA regulations weigh in on a recent batch of warning letters targeting new dietary ingredients marketed in supplements. Read More Previous Next

Find out which trailblazing startups were chosen for their innovative ingredients, finished products, and technologies for the 2024 Vitafoods Europe Startup Innovation Challenge. < Back Revealed: The 18 finalists of the 2024 Vitafoods Europe Startup Innovation Challenge Niamh Michail Press Mention Find out which trailblazing startups were chosen for their innovative ingredients, finished products, and technologies for the 2024 Vitafoods Europe Startup Innovation Challenge. Read More Previous Next

< Back Panel Discussion Friday Jun 25, 2021 Update on Cannabinoid Product Regulation Hemp Leaders Summit, Fort Lauderdale, Fl Asa Waldstein moderates this FDA and legal compliance panel. Richard Cleland , Assistant Director, Bureau of Consumer Protection, Division of Advertising Practices, Federal Trade Commission Dr. Matthew Curran , Food Safety Director, Florida Department of Agriculture and Consumer Services Learn More Previous Next

This edition talks about manufacturing essentials and reasons to think twice when building an overly robust Quality Management System (QMS). < Back Compliance Essentials for Hemp-CBD Companies Part 1 of 3 Asa Waldstein Guest Article This edition talks about manufacturing essentials and reasons to think twice when building an overly robust Quality Management System (QMS). Read More Previous Next

Asa and other industry leaders interviewed in the New Hope article. < Back FDA rejects two new dietary ingredient submissions for CBD, leaving hemp industry with legislation as only route to clarity Rick Polito Interview Asa and other industry leaders interviewed in the New Hope article. Read More Previous Next

Some of our favorite resources to help educate about labeling compliance. Labeling Compliance / Labeling Compliance These are common areas of enforcement and lawsuits.Here are some resources to help understand these regulations. FDA label claim guidance Compliance essentials for CBD companies: Labeling Back

Hemp Industry 2023 Opportunities Report < Back FDA Warning Letters, activity and actions in 2022 and what that means for 2023 Let's Talk Hemp Contributing Author Hemp Industry 2023 Opportunities Report Read More Previous Next

AsaWaldstein.com Terms of Service Please read these terms of service ("terms of service", "terms") carefully before using www.AsaWaldstein.com operated by Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com). Conditions of use By using this website, you certify that you have read and reviewed this Agreement and that you agree to comply with its terms. If you do not want to be bound by the terms of this Agreement, you are advised to leave the website accordingly. Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) only grants use and access of this website, its products, and its services to those who have accepted its terms. Privacy policy Before you continue using our website, we advise you to read our privacy policy regarding our user data collection. It will help you better understand our practices. Age restriction You must be at least 18 (eighteen) years of age before you can use this website. By using this website, you warrant that you are at least 18 years of age and you may legally adhere to this Agreement. Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) assumes no responsibility for liabilities related to age misrepresentation. Intellectual property You agree that all materials, products, and services provided on this website are the property of [name], its affiliates, directors, officers, employees, agents, suppliers, or licensors including all copyrights, trade secrets, trademarks, patents, and other intellectual property. You also agree that you will not reproduce or redistribute the [name]’s intellectual property in any way, including electronic, digital, or new trademark registrations. You grant Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) a royalty-free and non-exclusive license to display, use, copy, transmit, and broadcast the content you upload and publish. For issues regarding intellectual property claims, you should contact the company in order to come to an agreement. User accounts As a user of this website, you may be asked to register with us and provide private information. You are responsible for ensuring the accuracy of this information, and you are responsible for maintaining the safety and security of your identifying information. You are also responsible for all activities that occur under your account or password. If you think there are any possible issues regarding the security of your account on the website, inform us immediately so we may address it accordingly. We reserve all rights to terminate accounts, edit or remove content and cancel orders in their sole discretion. Applicable law By visiting this website, you agree that the laws of the [location], without regard to principles of conflict laws, will govern these terms and conditions, or any dispute of any sort that might come between Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) and you, or its business partners and associates. Disputes Any dispute related in any way to your visit to this website or to products you purchase from us shall be arbitrated by state or federal court [location] and you consent to exclusive jurisdiction and venue of such courts. Indemnification You agree to indemnify Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) and its affiliates and hold Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) harmless against legal claims and demands that may arise from your use or misuse of our services. We reserve the right to select our own legal counsel. Limitation on liability Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) is not liable for any damages that may occur to you as a result of your misuse of our website. Regulatory Education Events LLC dba Supplement Advisory Group LLC (AsaWaldstein.com) reserves the right to edit, modify, and change this Agreement any time. We shall let our users know of these changes through electronic mail. This Agreement is an understanding between Regulatory Education Events LLC dba Supplement Advisory Group LLC dba (AsaWaldstein.com) and the user, and this supersedes and replaces all prior agreements regarding the use of this website.

A weekly exploration of FDA warning letters and enforcement trends A weekly exploration of FDA warning letters and enforcement trends Get Warning Letter Wednesday in your Inbox Sign-Up Now! Select category Reset “Gum Detoxify” Claims Challenged Qualifying claims makes them easier to substantiate 8/20/25 Read More FTC Letters to Amazon, Walmart & Other Sellers Use caution with Made in USA claims 7/30/25 Read More NAD Case: Supporting Substantiation Ingredient studies may support product claims 7/9/25 Read More When Topical OTC Manufacturing Goes Wrong Test glycerin for contaminants 6/18/25 Read More Avoid Comparing Products to Drugs (most of the time) Use FDA’s helpful resource (criterion 6) 5/28/25 Read More Celebrating 200 Weekly WLW Posts! Learning from others' mistakes helps you be compliant 5/7/25 Read More OTC Topical “Inactive” Ingredient Marketing Claims “Extra” claims are often non-compliant 4/16/25 Read More Influencers Must Disclose Free Product Brands should monitor influencer posts for compliance 3/26/25 Read More Unallowable Ingredient “Enough” to Trigger Regulatory Action Delta-8 is a high-risk ingredient 8/13/25 Read More When Nutrient Claims Become Disease Statements Carefully review all marketing materials 7/23/25 Read More Dietary Supplement Manufacturing & Marketing Lessons Learn from others’ mistakes 7/2/25 Read More Labeling Lessons Minor label issues signal deeper compliance issues 6/11/25 Read More Unallowable Ingredient Results in Warning Letter Here are tips on using FDA’s ingredient directory 5/21/25 Read More Best Practices When Making Competitor Comparison Claims Ensure statements are not disparaging 4/30/25 Read More Best Practices When Making Biomarker and Implied Claims Use FDA’s helpful resource (Criterion 2) 4/9/25 Read More Injectable CBD Warning Letter Curated testimonials are marketing claims 3/19/25 Read More Product Reviews Are Marketing Claims Kratom 7-OH products are highly scrutinized 8/6/25 Read More Diseased Population Study Helps Trigger IND Requirement Dietary supplement clinical triggers should be thoughtfully considered 7/16/25 Read More Failure to Report Serious Adverse Events Investigating customer complaints is a cornerstone of supplement safety and compliance 6/25/25 Read More Delta-8 Inhalable Product Dangerous products will be cited even if they do not contain disease claims 6/4/25 Read More 3 Animal Product Companies Receive Warning Letters Extra attention is paid to animal CBD products 5/15/25 Read More Navigating the Risks of Therapy-Adjacent Health Claims Use FDA's helpful resource (Criterion 7) 4/23/25 Read More In-Process Quality Testing A look at the manufacturing and quality process 4/3/25 Read More Amazon & Others Cited for Selling Injectables Distributors are responsible for the products they distribute 3/12/25 Read More 1 2 3 ... 9 1 ... 1 2 3 4 5 6 7 8 9 ... 9